Trade Mark Journal No.2026/030 24 July 2026
UK00004379159 27 April 2026 (1,5,35,41,42,44)
MEDICINES360 ASPIRE
International priority date claimed: 11 November 2025
(United States of America)
(99491156)
- Class 1
- Reagents and assays for scientific and research use.
- Class 5
- Medical reagents and assays; Medical diagnostic reagents and assays; reagents and assays for use in treating, monitoring, testing, analyzing and detecting medical conditions, diseases and disorders in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; diagnostic biomarker reagents and assays for medical purposes.
- Class 35
- Promoting awareness of and organizing and developing projects to support women’s health.
- Class 41
- Educational services, including conducting classes, seminars, conferences, workshops, and online webinars for physicians and other medical service providers to provide instruction on the use of software and medical reagents and assays, and distribution of training materials in connection therewith.
- Class 42
- Providing medical and scientific research information in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; Providing online non-downloadable software for medical diagnostic testing or treatment; Software as a service (SAAS) services featuring software for medical assessment, diagnostic testing or treatment; Providing online non-downloadable software, for medical testing, reports for risk prediction and classification and information in the field of maternal health and health conditions during pregnancy and labor.
- Class 44
- Providing medical information in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; Medical diagnostic testing, monitoring and reporting services; providing medical information in the field of medical testing, risk prediction and classification of maternal health conditions and health conditions during pregnancy and labor.
Medicines 360
Representative: Meissner Bolte (UK) Limited